Literature DB >> 11584850

Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.

M Iester1, G J Orsoni, G Gamba, M Taffara, P Mangiafico, S Giuffrida, M Rolando.   

Abstract

BACKGROUND: The ocular surface changes of keratoconjunctivitis sicca (KCS) could be the result of the effect of an altered tear film on the epithelial environment.
PURPOSE: To evaluate the possibility of improving the environmental conditions of the ocular surface by lowering tear osmolarity, increasing tear film volume and stabilising the tear film. Also, to study the effect of such an improvement on the epithelial cells of the ocular surface.
METHODS: One hundred and thirty-five patients with a diagnosis of KCS were treated on a randomised basis with either unpreserved hypotonic 0.4% hyaluronic acid (HHA) eye drops or 0.3% hydroxypropylmethylcellulose plus 0.1% Dextran 70 (HPMC) eye drops 6 times a day for 60 or 90 days. In all patients a Schirmer I test, break-up time (BUT), ocular surface staining with 1% Bengal Rose, or 2% fluorescein, as well as subjective symptoms, were recorded before and 15, 30 and 60 days after the beginning of the study. Patients were divided into three subgroups and the effect of the treatment was studied using three different techniques: the tear ferning test, conjunctival impression cytology and tear osmolarity measurement.
RESULTS: Improvements in BUT, vital staining, Schirmer I and symptoms were recorded in both groups of treatment, with significant differences for patients treated with 0.4% HHA. On day 60, 30 min after installation: tear ferning patterns changed from 100% pathological (types III-IV) to 93% physiological (types I-II) in the 0.4% HHA group and from 100% pathological to 78% physiological in the 0.3% HPMC group (p < 0.01 between groups). Tear osmolarity shifted from 353 +/- 23 to 305 +/- 6 mosmol/l in the 0.4% HHA group and from 346 +/- 15 to 336 +/- 8 mosmol/l in the 0.3% HPMC group (p < 0.001 between groups). On day 90, the impression cytology score improved from 1.2 to 1.9 in the 0.4% HHA group while it did not change in the 0.3% HPMC group (p < 0.05 between groups).
CONCLUSION: In KCS appropriate treatment with a hypotonic 0.4% HHA tear substitute can change the tear environment and results in improvement of the epithelial conditions of the ocular surface.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11584850     DOI: 10.1038/eye.2000.244

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

Review 1.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

2.  Do different osmolar solutions change the epithelial surface of the healthy rabbit cornea?

Authors:  N Schrage; H Wuestemeyer; S Langefeld
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

3.  Daytime variations of tear osmolarity and tear meniscus volume.

Authors:  Ming Li; Chixin Du; Dexi Zhu; Meixiao Shen; Lele Cui; Jianhua Wang
Journal:  Eye Contact Lens       Date:  2012-09       Impact factor: 2.018

Review 4.  Tear Osmolarity in the Diagnosis of Systemic Dehydration and Dry Eye Disease.

Authors:  Anthony J Bron; Catherine Willshire
Journal:  Diagnostics (Basel)       Date:  2021-02-25

5.  Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Bryan Chin Hou Ang; James Jie Sng; Priscilla Xin Hui Wang; Hla Myint Htoon; Louis Hak Tien Tong
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).

Authors:  Monika Yadav; Nicola Schiavone; Ana Guzman-Aranguez; Fabrizio Giansanti; Laura Papucci; Maria J Perez de Lara; Mandeep Singh; Indu Pal Kaur
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 4.617

7.  Tear osmolarity after cataract surgery.

Authors:  Ēriks Elksnis; Ilze Lāce; Guna Laganovska; Renārs Erts
Journal:  J Curr Ophthalmol       Date:  2018-09-24

Review 8.  Over the counter (OTC) artificial tear drops for dry eye syndrome.

Authors:  Andrew D Pucker; Sueko M Ng; Jason J Nichols
Journal:  Cochrane Database Syst Rev       Date:  2016-02-23

9.  Progress in tear microdesiccate analysis by combining various transmitted-light microscope techniques.

Authors:  Felipe Traipe-Salas; Leonidas Traipe-Castro; Daniela Salinas-Toro; Daniela López; Felipe Valenzuela; Christian Cartes; Héctor Toledo-Araya; Claudio Pérez; Remigio López Solís
Journal:  Biol Res       Date:  2016-06-03       Impact factor: 5.612

Review 10.  Tear film osmolarity and dry eye disease: a review of the literature.

Authors:  Richard Potvin; Sarah Makari; Christopher J Rapuano
Journal:  Clin Ophthalmol       Date:  2015-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.